In continuation of previous studies, the intraarterial fusion of L-glUtamiC acid for 24 hr was found to oppose the decrease in acetylcholinesterase and butyrylcholinesterase in the superior cervical ganglion of the cat that otherwise occurs 48 hr after preganglionic denervation. The combination of glutamic acid and raminobutyric acid, in concentrations that were inactive individually, likewise produced the same neurotrophic effect. Inactive in this respect were glycine plus L-glutamine, pyroglutamic acid, y-aminobutyric acid, and L-aspartic acid. The possible mechanisms and implications of these rmdings are discussed.
Previous studies in this series have demonstrated that the 24-hr intracarotid infusion of an aqueous extract of cat brain, spinal cord, and sciatic nerves in cats opposes (1, 2) the fall in the acetylcholinesterase (AcChoEase; acetylcholine acetylhydrolase, EC 3.1.1.7) and butyrylcholinesterase (BtChoEase; acylcholine acylhydrolase, EC 3.1.1.8) contents of the superior cervical ganglia (SCG) that otherwise occurs 48 hr after section of the cervical sympathetic trunks (1, 3, 4) . The neurotrophic factor responsible for this effect was found to be a heat-stable compound of low molecular weight (Mr, <1000) and probably a peptide (5) . It was postulated (6) that the neurotrophic factor might act by regulating the conversion of the G1 to the G4 and A12 molecular aggregates of the enzymes (7) . Following a report (8) that glycyl-L-glutamine (Gly-Gln) exhibited such an effect in cultured embryonic rat and chicken skeletal muscle, and because this compound met the criteria indicated above, it was tested in the cat in vivo preparation. Results indicated that a metabolite of Gly-Gln is an active neurotrophic factor. Of three possible metabolites tested, glycine and L-glutamine were found to be inactive but glycyl-L-glutamic acid (GlyGlu) was significantly active (9) .
In the present study, we report the results of testing similarly some possible metabolites of Gly-Glu and related compounds. L-Glutamic acid was found to be an active neurotrophic factor when infused in the concentration range of 10 to 300 ,uM. The combination of 1 ,uM glutamic acid and 100 AM y-aminobutyric acid (GABA) in concentrations that were inactive individually was also effective. Combinations of glycine plus L-glutamine were inactive, as were pyroglutamic acid, GABA, and L-aspartic acid.
METHODS
Anesthetic and surgical procedures and the methods for homogenization of ganglia and for determination of their AcChoEase, BtChoEase, and protein contents and for calculation of statistical significance of mean differences were identical with those reported (1) . Under sodium pentobarbital anesthesia (35 mg/kg intraperitoneally) 1 cm was resected from both cervical sympathetic trunks; the wound was sutured and Combiotic (penicillin/dihydrostreptomycin, 0.5 ml intramuscularly; Pfizer, New York) was given. The following day, cats were again anesthetized, ifrecovered, and atropinized (1.0 mg/kg, intraperitoneal4y); artificial respiration was administered through a tracheal catheter attached to a Palmer pump, and a slow intravenous infusion of 5% glucose/0.45% NaCl was started. Heparin (50 units/kg, intravenously) was given just prior to bilateral ligation of the external carotid and lingual arteries and was repeated every 8 hr. Infusion ofthe solution under test in 0.9o NaCl solution was begun =24 hr after denervation and continued until the time of sacrifice, with a total of '400 ml. Solutions were infused by a 27-gauge hypodermic needle inserted into the right common carotid artery and attached by Tygon tubing to a reservoir enclosed in an ice-water bath. A Harvard peristaltic pump and a mercury manometer were interposed. Deep anesthesia was maintained by repeated intravenous doses of sodium pentobarbital as required; atropine or mephentermine was administered whenever wheezing respiration or persistent hypotension occurred. Exactly 48 hr postdenervation, the SCG and stellate ganglia were removed, weighed, and frozen until homogenization a few minutes later. AcChoEase and BtChoEase were assayed by a modification (10) of the method of Ellman et al. (11) , and protein was determined according to Lowry et al. (12) .
Control values for AcChoEase and BtChoEase contents of SCG were taken from previous reports (1, 2, 5, 9).
RESULTS
Controls. In three denervated control cats infused for 24 hr with 0.9o NaCl solution following ligation of the external carotid and lingual arteries ( Table 1 , group 5), the mean value for the AcChoEase contents of the SCG was practically identical with that of cats continuously anesthetized with sodium pentobarbital from the time of denervation to 48 hr later, but without the arterial ligations (group 4). The mean value for denervated cats that were temporarily reanesthetized at 24 hr for ligation of the external carotid and lingual arteries (group 3) was considerably lower, although it was still significantly higher than that for denervated controls that were otherwise untreated (group 2). It therefore appears that continuous anesthesia with sodium pentobarbital is the critical factor in reducing or delaying the loss of ganglionic AcChoEase after denervation and that it is not significantly influenced by ligation of the external carotid and lingual arteries. It is also apparent that group 5 constitutes the Abbreviations: AcChoEase, acetylcholinesterase; BtChoEase, butyrylcholinesterase; GABA, y-aminobutyric acid; SCG, superior cervical ganglion.
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Values for AcChoEase showed extreme variation in control and most subsequent test series; variation was even greater for BtChoEase, as indicated by the higher SEMs. Individual values therefore tend to be misleading, and conclusions can be drawn only from mean values obtained from at least three experiments that differ significantly from controls.
Experimental. It was found previously that glycine and L-glutamine, two possible metabolites of glycyl-L-glutamine, were inactive as neurotrophic factors (9) . The combination of both at 10 and 100 ,uM each was shown here to be ineffective (Table 2 , cats G and H).
Glutamic acid was apparently inactive at 1 ,uM (cats R, 0, and P), although marked variation occurred between individual experiments. It was significantly active at 10 AM (cats L, M, and N), 30 ,uM (cats X, Y, and B), and 100 ,uM (cats 0, P, and W) in the maintenance of AcChoEase in denervated SCG; at the last mentioned concentration, it also exhibited significant maintenance of BtChoEase. Although no effect was obtained in cat W, values in cats 0 and P were sufficiently high to elevate the means to significant levels. For a single cat (A) infused at 300 ,uM, neurotrophic activity was also apparent.
Pyroglutamic acid, which might be formed by internal rearrangement of glutamic acid, was inactive at 10 ,uM (cats C, D, and F) and 100 ,uM (cat E).
GABA, a metabolite of glutamic acid, was inactive at 10 ,uM (cat S). In the first cat (C) infused with 100 ,uM GABA, a markedly positive effect was obtained. However, this was not confirmed in subsequent experiments (cats D, E, and F). Since cat C was infused immediately after experiments in which high concentrations of glutamic acid had been used, the possibility was considered that this result might have been due to contamination of the infusion system, particularly the sidearm leading to the manometer, with glutamic acid. Accordingly, one cat was infused with a combination of 
DISCUSSION
In summary, neurotrophic activity was demonstrated in the present study with glutamic acid and with the combination of glutamic acid and GABA at concentrations that were individually ineffective; in the preceding report, similar activity was shown with Gly-Glu and, indirectly, with Gly-Gln (9). Negative results were obtained here with glycine plus glutamine, and with pyroglutamic acid, GABA, and aspartic acid, and previously with glycine and glutamine individually (9) . In an earlier study (5), negative results were found also with acetylcholine and nerve growth factor (7S and 2.5S), and findings were borderline with cyclic AMP. The interpretation of these results raises a number of questions.
It seems surprising that a positive neurotrophic effect was obtained with the infusion of glutamic acid into the arterial circulation of the SCG at a concentration as low as 10 ,uM. The concentration ofglutamic acid in human plasma has been reported to be in the same range-i.e., 22 + 11 AiM (13 (14) .
In comparison with glutamic acid, the concentrations of glutamine in plasma and cerebrospinal fluid are 1-3 orders of magnitude higher (14, 16) , whereas those of GABA are at least a magnitude lower or negligible (14, 17) . However, the concentrations of all three in brain are between 5 and 50 mM (14, 16 (19) . Plasma is devoid of both enzymes (20, 21) . Accordingly, neither endogenous nor infused glutamine or GABA would be expected to be converted to glutamic acid in the SCG with the present procedure.
The neurotrophic action demonstrated previously with glycyl-L-glutamic acid (9) (23) . Recently, some new dicarboxylic amino acid receptors have been discovered in rat hippocampus that couple with guanyl cyclase and with phosphatidylinositide-specific phospholipase A; the latter catalyzes the formation ofinositol phosphates (24) . Similar or additional receptors may be involved in the neurotrophic action.
Although the preceding and present studies have led to the demonstration that glutamic acid functions as a neurotrophic factor in vivo, they do not of course implicate it as the major compound that is responsible for this effect in dialysates of extracts of the central nervous system (5) , or physiologically in the maintenance of postsynaptic AcChoEase and BtChoEase in the normal cat SCG (25) . Values (Tables 3 and 4 in ref. 5) were considerably higher than those found here or previously (9) with authentic compounds. The present findings are also inconsistent with the earlier conclusion that the endogenous neurotrophic factor is probably a peptide (5). Thus, it is likely that the latter remains to be identified.
